ACUTUS MEDICAL INC (AFIB)

US0051111096 - Common Stock

0.153  +0 (+2%)

After market: 0.1534 +0 (+0.26%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
8.46M
197.89%		17.26M
104.02%		16.36M
-5.21%		21.216M
29.68%
EBITDA
YoY % growth
-88.11M
-27.22%		-105.73M
-20.00%		-85.93M
18.73%		-64.77M
24.62%
EBIT
YoY % growth
-91.33M
-27.22%		-112.12M
-22.76%		-92.41M
17.58%		-71.4M
22.74%
Operating Margin
-1,079.55%-649.59%-564.85%-336.54%
EPS
YoY % growth
N/A-4.12-2.69
34.71%		-2.36
12.16%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.54
-232.68%
Revenue
Q2Q % growth		6.64M
33.87%
EBITDA
Q2Q % growth		-16.065M
EBIT
Q2Q % growth		-17.85M
5.95%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 -0.45
37.50%		-0.620.1727.28%
Q2 2023
Q2Q % growth		 -0.63
54.35%		-0.650.023.49%
Q1 2023
Q2Q % growth		 -0.57
43.00%		-0.700.1319.01%
Q4 2022
Q2Q % growth		 0.41
136.61%		-0.721.13156.88%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 5.238M
43.90%		4.93M308K6.25%
Q2 2023
Q2Q % growth		 5.29M
29.66%		4.619M671K14.53%
Q1 2023
Q2Q % growth		 4.17M
13.32%		3.924M246K6.27%
Q4 2022
Q2Q % growth		 4.96M
13.76%		4.402M558K12.68%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%